| 颅内动脉粥样硬化性狭窄的治疗现状 |
| |
| 引用本文： | 许长敏,高利,罗玉敏. 颅内动脉粥样硬化性狭窄的治疗现状[J]. 国际脑血管病杂志, 2009, 18(9): 347-351. DOI: 10.3760/cma.j.issn.1673-4165.2010.005.006 |
| |
| 作者姓名： | 许长敏 高利 罗玉敏 |
| |
| 作者单位： | 首都医科大学宜武医院神经内科,北京,100053;首都医科大学脑血管病研究所,北京,100053; |
| |
| 摘 要： | 我国每年新发卒中200多万例,其中绝大部分由脑血管狭窄引起.动脉粥样硬化是脑血管狭窄的主要原因,有效治疗颅内动脉粥样硬化能明显降低卒中的发病率.然而,目前有关颅内动脉粥样硬化性狭窄的治疗并不规范,文章就近年来有关颅内动脉粥样硬化性狭窄的治疗方法做一综述,为颅内动脉粥样硬化性狭窄治疗规范的制定提供依据.
|
| 关 键 词： | 颅内动脉疾病 颅内动脉粥样硬化 卒中 脑缺血发作,短暂性 血小板聚集抑制剂 羟基甲基戊二酰基-CoA还原酶抑制剂 抗凝药 支架 |
Treatment status of intracranial atherosclerotic stenosis |
| |
| XU Chang-min,GAO Li,LUO Yu-min. Treatment status of intracranial atherosclerotic stenosis[J]. International Journal of Cerebrovascular Diseases, 2009, 18(9): 347-351. DOI: 10.3760/cma.j.issn.1673-4165.2010.005.006 |
| |
| Authors: | XU Chang-min GAO Li LUO Yu-min |
| |
| Abstract: | More than 2 million strokes occur in china each year,most of which are caused by cerebrovascular stenosis. Atherosclerosis is the main reason for cerebrovascular stenosis. The effective treatment of intracranial atherosclerosis can significantly decrease the incidence of stroke. However,at present,about the treatment of intracranial atherosclerotic stenosis has not been standardized. This article reviews about the treatment methods for intracranial atherosclerotic stenosis in recent years and provides the basis for the development of standardized treatment of intracranial atherosclerotic stenosis. |
| |
| Keywords: | Intracranial arterial diseasesIntracranial arteriosclerosisStrokeIschemic attack transientRisk factorsPlatelet aggregation nhibitorsAnticoagulantsHydroxymethylglutaryl-CoA reductase inhibitorsStents |
|
|
